Chairman, Division of Gastroenterology and Hepatology, Antwerp University Hospital
Date: 2 June 2021 (Wednesday)
Time: San Diego – 08:00 | Chicago – 10:00 | New York – 11:00 | London – 16:00 | Paris – 17:00 | Israel – 18:00 | Singapore – 23:00 | Tokyo – 00:00 (3 June 2021)
Duration: 90 minutes
Event structure: 15 min presentation x 3 + 40-min panel discussion
Registration fee: Complimentary access
Webinar on-demand: Available to view until midnight 16 June 2021 (registration is required)
Non-alcoholic steatohepatitis (NASH) is a growing health concern that affects millions of patients worldwide. NASH is often a silent disease with limited obvious symptoms at an early stage. Many patients remaining asymptomatic resulting in few patients actively seeking treatment. The public health implications of this disease have driven research and investment toward diagnostics and treatments, but many challenges remain in finding NASH patients for clinical trials. In this webinar, a panel of speakers will explore the challenges to successfully bring effective therapies to market and how we might overcome them.
Presentation Topics :
Panel Discussion: An expert view on NASH challenges in clinical trials and patient identification
Heisenberg-Professorship for Clinical and Experimental Diabetology, Head of Dept. Pathophysiology of Prediabetes of the Institute of Diabetes Research and Metabolic Diseases, Helmholtz Centre Munich and the University of Tubingen
Professor of Pathology, University of Paris, Visiting Professor at Translational and Clinical Research Institute, Faculty of Newcastle, UK
PRESENTERS / PANELISTS :
With over a decade of experience in hosting life science events, Global Engage is your ideal partner to either devise an agenda for you or work with you and your speakers to promote the online event to our extensive databases.